Elevra Lithium Ltd

Elevra Lithium Ltd. has announced its 2026 Annual General Meeting (AGM) will be held on November 19, 2026, as a hybrid meeting. The agenda includes the presentation of financial reports and several resolutions, including the adoption of the Remuneration Report, the re-election of Director James Brown, and the approval of performance rights grants for the Managing Director and CEO, Lucas Dow. Additionally, two Non-Executive Directors, Allan Buckler and Jorge Beristain, will resign as part of a planned reduction in Board size from eight to six directors.

Elevra Lithium Limited has completed the sale of its rights, interests, and obligations on E45/2364 in Western Australia (Tabba Tabba) to Wildcat Resources Limited. The transaction involves a total consideration of A$16 million, comprising A$5 million cash on completion, A$8 million in Wildcat shares, and A$3 million in deferred cash, plus an ongoing royalty. This divestment allows Elevra to unlock immediate value from a non-core asset and reallocate capital to further develop its core North American assets and growth strategy.

Elevra Lithium Limited has completed the divestment of its rights, interests, and obligations on the E45/2364 project in Western Australia, known as Tabba Tabba, to Wildcat Resources Limited. The transaction is valued at $16 million, comprising A$5 million in cash, A$8 million in Wildcat shares, A$3 million in deferred cash, and contingent royalty payments. This move allows Elevra to unlock immediate value from a non-core asset and reallocate capital to its North American growth strategy, including the NAL Brownfield Expansion.

Elevra Lithium Ltd. announced the issuance of C$65 million in Upfront Tranche Convertible Notes to a subsidiary of Canada Growth Fund Inc. This financing, approved by shareholders, will be used to fund the staged expansion of the North American Lithium (NAL) Brownfield Expansion and provide additional liquidity. The notes have a five-year maturity, accrue interest at CORRA plus 225 basis points, and have a conversion price of A$17.17 per share. This issuance is part of a broader financing package designed to increase production capacity and reduce unit operating costs.

Elevra Lithium reported strong operational performance in Q2 2026, with spodumene concentrate production up 15% QoQ to 54,479 dmt and lithium recoveries improving to 71%. The company secured a significant Strategic Financing Package of approximately US$298 million to fully fund the NAL Expansion and advance the Moblan Project. However, Q2 revenue declined 61% QoQ to US$31 million due to a legacy contract with lagged pricing, though future pricing is expected to align with spot rates. Elevra also divested its Ewoyaa Project interest for US$71 million to streamline its portfolio and ended the quarter with US$255 million in cash.

Elevra Lithium reported strong operational performance in Q2 FY26, achieving record monthly production at North American Lithium (NAL) with a 15% QoQ increase in spodumene concentrate to 54,479 dmt. The company secured a US$298 million Strategic Financing Package to fully fund the NAL Expansion, which is now underway and expected to double the project's incremental post-tax NPV to C$969 million. Additionally, Elevra divested its interest in the Ewoyaa Project for US$71 million to streamline its portfolio and focus on North American assets. While revenue declined due to a legacy contract, future pricing is expected to align with spot prices.

Elevra Lithium Limited has announced the scheduled release of its June 2026 Quarterly Activities Report for Tuesday, July 28, 2026. The company will host an investor webcast to discuss the quarterly results on the same day at 9:30 AM AEST, which corresponds to Monday, July 27, 2026, at 7:30 PM EDT. Shareholders and investors are invited to register for the webcast, with an archived version available shortly after the live event.

Elevra Lithium Ltd has announced that its June 2026 Quarterly Activities Report will be released on Tuesday, July 28, 2026 AEST. The company will also host an investor webcast to discuss the quarterly results, commencing at 9:30 AM AEST on the same day. Shareholders and investors are invited to register for the webcast, which will also allow for the submission of written questions.

Elevra Lithium Ltd. detailed its phased North American Lithium (NAL) Brownfield Expansion strategy, aiming to increase annual spodumene concentrate production capacity by approximately 74% and decrease unit operating costs by around 21%. The company secured a strategic financing package totaling A$508 million (US$368 million) to fully fund the expansion, comprising a A$275 million equity placement, A$146 million in convertible notes from Canada Growth Fund, and A$87 million net proceeds from the divestment of the Ewoyaa Project. All proposed funding arrangements and other resolutions were approved by shareholders at the Extraordinary General Meeting.

Elevra Lithium Limited provided an operational update for its North American Lithium (NAL) operation for the June 2026 quarter. The company produced approximately 54,479 dry metric tonnes (dmt) of spodumene concentrate, marking a 15% increase from the previous quarter and the second highest quarterly production to date. Sales volumes reached 33,977 dmt at an average realized price of US$919 per dmt, which was below current spot prices due to lagged contractual mechanisms, but future pricing is expected to align more closely with spot rates. Additionally, the company issued 2,160 performance rights under an employee incentive scheme.